133 related articles for article (PubMed ID: 36898255)
1. Stigmasterol isolated from Azadirachta indica flowers attenuated glutamate-induced neurotoxicity via downregulation of the Cdk5/p35/p25 signaling pathway in the HT-22 cells.
Mongkolpobsin K; Sillapachaiyaporn C; Nilkhet S; Tencomnao T; Baek SJ
Phytomedicine; 2023 May; 113():154728. PubMed ID: 36898255
[TBL] [Abstract][Full Text] [Related]
2. Involvement of calpain/p35-p25/Cdk5/NMDAR signaling pathway in glutamate-induced neurotoxicity in cultured rat retinal neurons.
Miao Y; Dong LD; Chen J; Hu XC; Yang XL; Wang Z
PLoS One; 2012; 7(8):e42318. PubMed ID: 22870316
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
4. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
[TBL] [Abstract][Full Text] [Related]
5. The protective effects of tanshinone IIA on neurotoxicity induced by β-amyloid protein through calpain and the p35/Cdk5 pathway in primary cortical neurons.
Shi LL; Yang WN; Chen XL; Zhang JS; Yang PB; Hu XD; Han H; Qian YH; Liu Y
Neurochem Int; 2012 Jul; 61(2):227-35. PubMed ID: 22561406
[TBL] [Abstract][Full Text] [Related]
6. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
[TBL] [Abstract][Full Text] [Related]
7. p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.
Zhang L; Liu W; Szumlinski KK; Lew J
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20041-6. PubMed ID: 23151508
[TBL] [Abstract][Full Text] [Related]
8. No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro.
Peterson DW; Ando DM; Taketa DA; Zhou H; Dahlquist FW; Lew J
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2884-9. PubMed ID: 20133653
[TBL] [Abstract][Full Text] [Related]
9. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin-1β Plays a Neuroprotective Role by Inhibiting the Cdk5 Signaling Pathway after Cerebral Ischemia-Reperfusion Injury in Rats.
Zhang R; Liu C; Ji Y; Teng L; Guo Y
J Mol Neurosci; 2018 Oct; 66(2):261-272. PubMed ID: 30206770
[TBL] [Abstract][Full Text] [Related]
11. The potential LXRβ agonist stigmasterol protects against hypoxia/reoxygenation injury by modulating mitophagy in primary hippocampal neurons.
Haque MN; Hannan MA; Dash R; Choi SM; Moon IS
Phytomedicine; 2021 Jan; 81():153415. PubMed ID: 33285471
[TBL] [Abstract][Full Text] [Related]
12. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
[TBL] [Abstract][Full Text] [Related]
13. The role of CDK5/P25 formation/inhibition in neurodegeneration.
Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
[TBL] [Abstract][Full Text] [Related]
14. A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation.
Zheng YL; Amin ND; Hu YF; Rudrabhatla P; Shukla V; Kanungo J; Kesavapany S; Grant P; Albers W; Pant HC
J Biol Chem; 2010 Oct; 285(44):34202-12. PubMed ID: 20720012
[TBL] [Abstract][Full Text] [Related]
15. Glutamate treatment and p25 transfection increase Cdk5 mediated tau phosphorylation in SH-SY5Y cells.
Jämsä A; Bäckström A; Gustafsson E; Dehvari N; Hiller G; Cowburn RF; Vasänge M
Biochem Biophys Res Commun; 2006 Jun; 345(1):324-31. PubMed ID: 16678793
[TBL] [Abstract][Full Text] [Related]
16. Dendritic distribution of CDK5 mRNA and p35 mRNA, and a glutamate-responsive increase of CDK5/p25 complex contribute to tau hyperphosphorylation.
Tanaka T; Ohashi S; Takashima A; Kobayashi S
Biochim Biophys Acta Gen Subj; 2022 Jul; 1866(7):130135. PubMed ID: 35358667
[TBL] [Abstract][Full Text] [Related]
17. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.
Tomizawa K; Ohta J; Matsushita M; Moriwaki A; Li ST; Takei K; Matsui H
J Neurosci; 2002 Apr; 22(7):2590-7. PubMed ID: 11923424
[TBL] [Abstract][Full Text] [Related]
18. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
[TBL] [Abstract][Full Text] [Related]
19. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
20. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
